Australia markets closed

ABL Diagnostics (ABLDP.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
2.7500-2.7500 (-100.00%)
At close: 08:03AM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
11,625
8,749
0
0
0
Cost of revenue
-
426.696
101.636
87.205
66.473
Gross profit
-
8,322
-101.636
-87.205
-66.473
Operating expenses
Total operating expenses
10,839
8,263
102.624
91.161
69.263
Operating income or loss
-286.77
59.281
-102.624
-91.161
-69.263
Interest expense
-
12.82
-
-
-
Income before tax
144.474
490.525
295.955
-89.296
-62.937
Income tax expense
-
-615.152
38.086
-
-
Income from continuing operations
759.626
1,106
257.869
-89.296
-62.937
Net income
759.625
1,106
257.868
-89.296
-62.937
Net income available to common shareholders
759.625
1,106
257.868
-89.296
-62.937
Basic EPS
0.10
0.07
0.13
-0.04
-0.03
Diluted EPS
0.10
0.07
0.13
-0.04
-0.03
Basic average shares
16,114
16,114
2,006
2,006
2,006
Diluted average shares
16,114
16,114
2,006
2,006
2,006